Anodyne| 25I-NBOMe | |
|---|---|
 |
| Salts [] | |
|---|---|
| 25I-NBOMe hydrochloride | |
|
| Molecular structure via molpic | |
| Conformer structure via 3Dmol.js | |
| Molecular formula | C18H22INO3[1] |
|---|---|
| Molecular mass | 427.3 g/mol[1] |
| Predicted LogP | 3.8[1] |
| Chirality | achiral[2] |
| Identifiers [] | |
|---|---|
| IUPAC name | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine[1] |
| SMILES | COC1=CC=CC=C1CNCCC2=CC(=C(C=C2OC)I)OC[1] |
| InChI | InChI=1S/C18H22INO3/c1-21-16-7-5-4-6-14(16)12-20-9-8-13-10-18(23-3)15(19)11-17(13)22-2/h4-7,10-11,20H,8-9,12H2,1-3H3[1] |
| InChIKey | ZFUOLNAKPBFDIJ-UHFFFAOYSA-N[1] |
| Dosing | |
|---|---|
| Duration of action | Insufflation: 4–6 hSublingual administration|Sublingual: 6–10 hBuccal administration|Buccal: 6–10 h |
| Insufflated [] | |
|---|---|
| Threshold | 1 - 1.5 µg |
| Light | 1.5 - 3 µg |
| Common | 3 - 125 µg |
| Strong | 125 - 400 µg |
| Heavy | 400 - 500 µg |
| Oral [] | |
|---|---|
| Threshold | 0.5 - 1 hit |
| Light | 1 hit |
| Common | 1 hit |
| Strong | 1 - 2 hit |
| Heavy | 2 hit |
| Sublingual [] | |
|---|---|
| Threshold | 0.25 - 0.7000000000000002 mg |
| Light | 0.7000000000000002 - 1 mg |
| Common | 1 mg |
| Strong | 1 - 2 mg |
| Heavy | 2 - 2.460000000000001 mg |
| Statistically derived dosages by Sernyl |
25I-NBOMe
25I-NBOMe (also known as 2C-I-NBOMe, Cimbi-5, N-bomb, NBOMe-2C-I, 2C-I-NMBOMe, 4-Iodo-2,5-dimethoxy-N-((2-methoxyphenyl)methyl)-benzeneethanamine, 2-(4-iodo-2,5-dimethoxyphenyl)-n-(2-methoxybenzyl)ethanamine, 2-(4-Iodo-2,5-dimethoxyphenyl)-N-((2-methoxyphenyl)methyl)ethanamine, 2,5-Dimethoxy-4-iodo-n-(2-methoxybenzyl)phenethylamine or Benzeneethanamine, 4-iodo-2,5-dimethoxy-n-((2-methoxyphenyl)methyl)-) is a psychedelic substance of the 2,5-dimethoxyphenethylamine class.
Chemistry
25I-NBOMe is typically found in the form of its hydrochloride salt.
Stereochemistry
25I-NBOMe is a achiral mixture
Legal status
- Brazil: 25I-NBOMe is a F2.[3]
- United Kingdom: 25I-NBOMe is a Class A.
- United States: 25I-NBOMe is a Schedule I under the "Controlled Substances Act (CSA)".
- Germany: 25I-NBOMe is a Anlage I.
- European Union: 25I-NBOMe is a Controlled.
- Canada: 25I-NBOMe is a Schedule III.
- United Nations: 25I-NBOMe is a Schedule I under the "Convention on Psychotropic Substances 1971".
See also
External links
- 25I-NBOMe (Wikipedia)
- 25I-NBOMe (Wikidata)
- 25I-NBOMe (PubChem)
- 25I-NBOMe (ChEMBL)
- 25I-NBOMe (Probes & Drugs)
- 25I-NBOMe (Common Chemistry)
- 25I-NBOMe (HMDB)
- 25I-NBOMe (KEGG)
- 25I-NBOMe (UNII)
- 25I-NBOMe (EPA DSSTox)
References
National Center for Biotechnology Information. PubChem Compound Summary for CID 10251906, 25I-NBOMe. Accessed June 17, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/10251906.
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 25I-NBOMe. UNII: 547KGL06IP. Global Substance Registration System. Accessed June 17, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/547KGL06IP
Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. Accessed June 17, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451